To Assess Compliance With a Once-daily Regimen of Lamivudine, Efavirenz and Didanosine
This study has been completed.
Merck Sharp & Dohme Corp.
Information provided by:
First received: September 12, 2005
Last updated: April 8, 2011
Last verified: April 2011
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||December 2006|
|Primary Completion Date:||December 2006 (Final data collection date for primary outcome measure)|